Øystein Rekdal

Chief Executive Officer at LYTIX BIOPHARMA ASA

Net worth: 201 262 $ as of 31/05/2026

Health Technology

Consumer Services

Profile

Øystein Rekdal is the founder of Lytix Biopharma AS, serving as Chief Executive Officer & Media Relations Contact since 2019, founded in 2003.
Dr. Rekdal is a Professor at the University of Tromso.
Formerly, Dr. Rekdal worked as Director at Prophylix AS.
Education includes a doctorate from the University of Tromso.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
LYTIX BIOPHARMA ASA 0.23%	11/12/2025	1,76,179 ( 0.23% )	201 262 $	31/05/2026

Øystein Rekdal active positions

Companies	Position	Start
LYTIX BIOPHARMA ASA	Chief Executive Officer	11/09/2019
University of Tromso University of Tromso Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

All active positions of Øystein Rekdal

Former positions of Øystein Rekdal

Companies	Position	End
Prophylix AS Prophylix AS Pharmaceuticals: MajorHealth Technology Provides prophylactic medicinal product for newborns	Director/Board Member	-

See the detail of Øystein Rekdal's experience

Training of Øystein Rekdal

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Øystein Rekdal's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
University of Tromso University of Tromso Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lytix Biopharma AS Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies	Health Technology
Prophylix AS Prophylix AS Pharmaceuticals: MajorHealth Technology Provides prophylactic medicinal product for newborns	Health Technology